Ionis Pharmaceuticals (IONS) Other Operating Expenses (2010 - 2026)
Ionis Pharmaceuticals (IONS) posted quarterly Other Operating Expenses of $2.7 million for Q2 2026, down 34.02% year-over-year from $4.2 million in Q2 2025, and down 8.18% quarter-over-quarter from $3.0 million in Q1 2026.
Ionis Pharmaceuticals (IONS) Other Operating Expenses (2010 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Other Operating Expenses history runs 13 years deep, the most recent figure standing at $2.7 million for Q2 2026.
- In Q2 2026, Other Operating Expenses fell 34.02% year-over-year to $2.7 million; the TTM figure through Jun 2026 stood at $16.0 million (up 52.34% YoY), while the FY2025 annual figure was $15.9 million, up 132675.0% from the prior year.
- Other Operating Expenses for Q2 2026 stood at $2.7 million, down from $3.0 million in the prior quarter.
- The five-year high for Other Operating Expenses was $756.8 million in Q4 2022, with the low at $1.1 million in Q3 2024.
- The 5-year median for Other Operating Expenses is $2.9 million (2026), against an average of $45.0 million.
- The sharpest annual moves came in 2023 and 2025: Other Operating Expenses sank 99.6% in 2023, then jumped 118.3% in 2025.
- Ionis Pharmaceuticals' Other Operating Expenses stood at $756.8 million in 2022, then tumbled by 99.6% to $3.1 million in 2023, then rose by 25.09% to $3.8 million in 2024, then surged by 107.81% to $8.0 million in 2025, then sank by 65.58% to $2.7 million in 2026.
- Business Quant data shows IONS's Other Operating Expenses at $2.7 million in Q2 2026, $3.0 million in Q1 2026, and $8.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Ionis Pharmaceuticals | 9.48 Bn | 7.43 Bn | 265.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.74 Mn |
| Mar 31, 2026 | 2.98 Mn |
| Dec 31, 2025 | 7.96 Mn |
| Sep 30, 2025 | 2.34 Mn |
| Jun 30, 2025 | 4.15 Mn |
| Mar 31, 2025 | 1.46 Mn |
| Dec 31, 2024 | 3.83 Mn |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 4.16 Mn |
| Mar 31, 2024 | 2.15 Mn |
| Dec 31, 2023 | 3.06 Mn |
| Sep 30, 2023 | 2.19 Mn |
| Jun 30, 2023 | 2.54 Mn |
| Mar 31, 2023 | 1.34 Mn |
| Dec 31, 2022 | 756.83 Mn |
| Sep 30, 2022 | 1.52 Mn |
| Jun 30, 2022 | 4.75 Mn |
| Mar 31, 2022 | 4.17 Mn |
| Dec 31, 2021 | 610.88 Mn |
| Sep 30, 2021 | 3.08 Mn |